E-LIB Suche - Ergebnisse für: Alicandro G

1

P177 Impact of elexacafor/ivacaftor/tezacaftor therapy on A..:

Lanfranchi, C. ; Alicandro, G. ; Claut, L....
Journal of Cystic Fibrosis. 23 (2024) - p. S110 , 2024

Link: https://doi.org/10.1016/..

2

P169 Lung clearance index as an alternative respiratory out..:

Alicandro, G. ; Nazzari, E. ; Zazzeron, L....
Journal of Cystic Fibrosis. 23 (2024) - p. S107 , 2024

Link: https://doi.org/10.1016/..

3

WS07.05 Cardiometabolic risk factors in individuals with cy..:

Leonardi, G. ; Alicandro, G. ; Ruscica, M...
Journal of Cystic Fibrosis. 23 (2024) - p. S13-S14 , 2024

Link: https://doi.org/10.1016/..

4

P155 The impact of elexacaftor/tezacaftor/ivacaftor (ETI) t..:

Cariani, L. ; Alicandro, G. ; Teri, A....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..

5

WS06.04 Lung volumes as possible factors explaining the het..:

Premuda, C. ; Gramegna, A. ; Alicandro, G....
Journal of Cystic Fibrosis. 22 (2023) - p. S13 , 2023

Link: https://doi.org/10.1016/..

6

574 Effects on metabolic control and body composition of in..:

Zazzeron, L. ; Grancini, V. ; Alicandro, G....
Journal of Cystic Fibrosis. 22 (2023) - p. S303-S304 , 2023

Link: https://doi.org/10.1016/..

7

P154 Cluster analysis explains heterogeneity in treatment r..:

Gramegna, A. ; Alicandro, G. ; Retucci, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..

8

Humoral and cell-mediated immune responses to BNT162b2 vacc..:

Alicandro, G. ; Orena, B.S. ; Rosazza, C....
Vaccine. 41 (2023) 28 - p. 4114-4120 , 2023

Link: https://doi.org/10.1016/..

9

718 Lung clearance index decreases in patients who do not a..:

Nazzari, E. ; Alicandro, G. ; Zazzeron, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S396-S397 , 2023

Link: https://doi.org/10.1016/..

10

P153 An Italian centre experience with elexacaftor/tezacaft..:

Rosazza, C. ; Alicandro, G. ; Zazzeron, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..

11

Effects of insulin therapy optimization with sensor augment..:

Grancini, V. ; Alicandro, G. ; Porcaro, L. L....
Frontiers in Endocrinology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

12

719 Elexacaftor-tezacaftor-ivacaftor therapy improves early..:

Zazzeron, L. ; Alicandro, G. ; Nazzari, E....
Journal of Cystic Fibrosis. 22 (2023) - p. S397 , 2023

Link: https://doi.org/10.1016/..

13

P287 Characterisation of CFTR mutations in people with cyst..:

Colombo, C. ; Alicandro, G. ; Ramm, G....
Journal of Cystic Fibrosis. 22 (2023) - p. S153 , 2023

Link: https://doi.org/10.1016/..

14

532 Humoral and cell-mediated responses to BNT162b2 mRNA va..:

Daccò, V. ; Cariani, L. ; Alicandro, G....
Journal of Cystic Fibrosis. 21 (2022) - p. S297 , 2022

Link: https://doi.org/10.1016/..

15

P054 Severity of COVID-19 infection in cystic fibrosis pati..:

Rosazza, C. ; Medino, P. ; Bandera, A....
Journal of Cystic Fibrosis. 21 (2022) - p. S76 , 2022

Link: https://doi.org/10.1016/..